Table III.
Respective impact of melanoma (MSC) and basal cell carcinoma (BCC) on the professional life in professionally active patients
| MSC (total n = 143) | BCC (total n = 68) | p-value | |
|---|---|---|---|
| Patients missed working days over the last 6 months | 42.0 (58/138*) | 28.6 (18/63*) | 0.1101b |
| Unplanned absences at work, % (n) | 40.7 (22/54*) | 31.2 (5/16*) | 0.4933a |
| Number of days stopped, mean ± SD | 28 ± 54 | 15 ± 25 | 0.2838c |
| Reason for absence, % (n) | |||
| Medical appointment | 79.3 (46/58*) | 61.1 (11/18*) | 0.1319b |
| Cancer treatment | 41.4 (24/58*) | 50.0 (9/18*) | 0.5192a |
| Important fatigues due to cancer | 8.6 (5/58*) | 5.5 (1/18*) | 1.0b |
| Need to stay alone | 5.2 (3/58*) | 5.5 (1/18*) | 1.0b |
| Patients had to adapt working hours, % (n) | 14.5 (18/124*) | 3.9 (2/51*) | 0.1237b |
| Patients had to ask for a therapeutic part-time work, % (n) | 8.1 (10/124*) | 0 (0) | 0.0781b |
| Patients having experienced a loss of efficacy at work, % (n) | 21.9 (27/123*) | 14.0 (7/50*) | 0.4347b |
| Patients having experienced an income loss, % (n) | 8.9 (11/123*) | 6.0 (3/50*) | 0.576b |
| Patients having met difficulties to obtain a loan, % (n) | 20.3 (25/123*) | 6.0 (3/50*) | 0.0363 a |
a
χ2 test.
b
Fisher’s exact test.
c
Kuskal–Wallis test.
#
Patients with available data.
Patients had to choose from 5 possible answers: “never”, “rarely”, “sometimes”, “often” and “very often”. The percentages reported in this sub-section corresponded to all patients who answered “sometimes”, “often” or “very often”. Bold p-values indicate significance.